Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Zarate, C. A. Articles by Manji, H. K. Search for Related Content PubMed Citation Articles by Zarate, C. A., Jr. Articles by Manji, H. K. Neurophysiology Depression Other Somatic Therapy

An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression

OBJECTIVE: This study was conducted to determine the efficacy and safety of riluzole, a glutamate-modulating agent, in patients with recurrent major depression. METHOD: After a 1-week drug-free period, subjects 18 years or older with a diagnosis of recurrent major depression and a Montgomery-Åsberg Depression Rating Scale score 20 received riluzole monotherapy (100–200 mg/day) openly for 6 weeks. RESULTS: Nineteen treatment-resistant depressed patients, 53% of whom were classified as having stage 2 treatment resistance or greater, received riluzole at a mean dose of 169 mg/day. Significant improvement occurred during weeks 3 through 6 for all patients and weeks 2 through 6 for completers. CONCLUSIONS: Although preliminary, these results indicate that riluzole may have antidepressant properties in some patients.

This article has been cited by other articles:

				S. Chourbaji, M. A. Vogt, F. Fumagalli, R. Sohr, A. Frasca, C. Brandwein, H. Hortnagl, M. A. Riva, R. Sprengel, and P. Gass AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression FASEB J, September 1, 2008; 22(9): 3129 - 3134. [Abstract] [Full Text] [PDF]

				C. A. Zarate Jr, J. B. Singh, P. J. Carlson, N. E. Brutsche, R. Ameli, D. A. Luckenbaugh, D. S. Charney, and H. K. Manji A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression. Arch Gen Psychiatry, August 1, 2006; 63(8): 856 - 864. [Abstract] [Full Text] [PDF]

				C. A. Zarate Jr., J. B. Singh, J. A. Quiroz, G. De Jesus, K. K. Denicoff, D. A. Luckenbaugh, H. K. Manji, and D. S. Charney A Double-Blind, Placebo-Controlled Study of Memantine in the Treatment of Major Depression Am J Psychiatry, January 1, 2006; 163(1): 153 - 155. [Abstract] [Full Text] [PDF]

				S. J. Mathew, J. M. Amiel, J. D. Coplan, H. A. Fitterling, H. A. Sackeim, and J. M. Gorman Open-Label Trial of Riluzole in Generalized Anxiety Disorder Am J Psychiatry, December 1, 2005; 162(12): 2379 - 2381. [Abstract] [Full Text] [PDF]

				G. SANACORA, S. F. KENDELL, L. FENTON, V. CORIC, and J. H. KRYSTAL Riluzole Augmentation for Treatment-Resistant Depression Am J Psychiatry, November 1, 2004; 161(11): 2132 - 2132. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us